Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion

Clinical Reproduction and Fertility, 1(2), 131-135

Source

Abstract

A preliminary study of 'screened' women with two consecutive miscarriages revealed an incidence of abortion in 47.4% in a subsequent pregnancy whilst hCG therapy in a similar group of women where biochemical monitoring with plasma progesterone suggested a potentially jeopardized pregnancy resulted in a continuing pregnancy in 92.3% of treated women. An urgent need for a true randomized double-blind evaluation of this therapy has been established in order to re-examine the therapeutic nihilism which currently pervades the management of women with recurrent abortion.

Topics

hCG therapy recurrent miscarriage preliminary study, human chorionic gonadotrophin repeated abortion treatment, plasma progesterone monitoring threatened pregnancy hCG, recurrent spontaneous abortion progesterone support hCG, Svigos hCG recurrent miscarriage biochemical monitoring, luteal support hCG therapy pregnancy continuation rate, recurrent pregnancy loss hormonal treatment early pregnancy, progesterone jeopardized pregnancy hCG supplementation, randomized controlled trial need recurrent abortion therapy, biochemical monitoring early pregnancy loss prevention

Cite this article

Svigos, J. (1982). Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion. *Clinical reproduction and fertility*, *1*(2), 131-135.

Related articles